Fennec Pharmaceuticals Inc. (TSX:FRX)
Canada flag Canada · Delayed Price · Currency is CAD
11.33
0.00 (0.00%)
Jun 4, 2025, 9:30 AM EDT

Fennec Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-14.44-0.44-16.05-23.71-17.35-18.11
Upgrade
Other Amortization
0.950.960.290.150.020.4
Upgrade
Loss (Gain) From Sale of Investments
0.070.080.040.180.03-0.1
Upgrade
Stock-Based Compensation
4.675.065.354.224.012.88
Upgrade
Provision & Write-off of Bad Debts
3.883.8----
Upgrade
Other Operating Activities
0.170.57----
Upgrade
Change in Accounts Receivable
-11.69-7.87-7.27-1.55--
Upgrade
Change in Inventory
0.140.58-1.58-0.58--
Upgrade
Change in Accounts Payable
0.08-0.541.391.61-0.79-0.04
Upgrade
Change in Unearned Revenue
-0.4424.81----
Upgrade
Change in Other Net Operating Assets
0.92-0.040.681.61-0.14-0.62
Upgrade
Operating Cash Flow
-16.3926.98-17.14-18.06-14.22-15.6
Upgrade
Long-Term Debt Issued
--525.175-
Upgrade
Long-Term Debt Repaid
--13--5-0.01-
Upgrade
Net Debt Issued (Repaid)
-13-13520.174.99-
Upgrade
Issuance of Common Stock
1.051.31.720.930.0332.43
Upgrade
Repurchase of Common Stock
-0.17-0.18-0.08-0.19--
Upgrade
Other Financing Activities
--1.74--0.18-0.04-0.14
Upgrade
Financing Cash Flow
-12.12-13.626.6420.734.9832.29
Upgrade
Net Cash Flow
-28.5113.37-10.512.67-9.2416.69
Upgrade
Levered Free Cash Flow
-9.650.51-12.35-9.17-7.73-8.92
Upgrade
Unlevered Free Cash Flow
-7.482.95-10.34-8.61-7.66-9.07
Upgrade
Change in Net Working Capital
4.764.527.71-1.290.910.76
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.